EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Prevalence of Bone Marrow–Confirmed Hematological Malignancies in Patients with Abnormal Blood Parameters: A Systematic Review and Meta-Analysis 2025

Misgana Woldemeskel **, Haile Derese Degefa, Yodit Abera Germame, Eyerusalem Getaneh Workineh, Bereket Muhabaw Agedaw *, Maria Bilal Mohammed *, Leilt Zewdie Wachemo, Yared Getachew Alemu, Thomas Daba Balcha, Blen Gebremeskel, Aryamawit Neway Habteyesus, Dagmawi Workalemahu Tesfaye und 5 weitere

Clinical Oncology Research and Reports · 16.01.2026 · 05 (01) · 01-07

DOI: 10.31579/2693-4787/050 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Oncology Research and Reports, online erschienen am 16.01.2026. Verfasst von Misgana Woldemeskel ** und 16 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hematologic malignancies remained a major global public health issue and the leading cause of global tumor burden. It significantly affects patients' overall health-related quality of life, financial toxicity, physical distress, and mental health challenges. So this study is aimed to estimate burden of bone marrow confirmed malignant hematological disorders in patients with abnormal hematological parameter.

Method

And Materials: Both manual and electronic searches were used to extract studies for this meta-analysis from PubMed, Google Scholar, Scopus, DOAJ, Web of Science, and Google databases were utilized to identify the eligible articles. Then identified articles were exported into EndNote software used to export, organize, and review, the eligible articles. The quality of studies was assessed by using the Newcastle-Ottawa Scale quality appraisal tool for prevalence study. Meta-analysis was carried out using a random-effects method using the STATA™ Version 14 software.

Result

Nine included studies with a total of 31, 564 participants enrolled in this study. According to this study the pooled proportion of malignant hematological disorders in Ethiopia was found to be 8.47% (95% CI: 5.28-11.65) with range of 2.8%-17.2%. The highest prevalence of hematological malignancy is 11.92 % (95% CI: 4.30- 19.54) was seen in northern region, and the lowest is 5.82 % (95% CI: 1.78.-9.86) was seen in central region.

Conclusion

According to these findings the pooled prevalence of malignant hematological disorders substantial in Ethiopia. Also, the findings highlight marked geographic disparities. So strengthening of hematologic diagnostic and treatment services are essential to ensure earlier detection and better management of hematologic malignancies across the country.

Zitieren

APA

**, M. W., Degefa, H. D., Germame, Y. A., Workineh, E. G., *, B. M. A., *, M. B. M., Wachemo, L. Z., Alemu, Y. G., Balcha, T. D., Gebremeskel, B., Habteyesus, A. N., Tesfaye, D. W., Ashenafi, M. M., Chane, L. G., *, F. G., Dechassa, T. T., & Tarekegn, T. K. (2026). Prevalence of Bone Marrow–Confirmed Hematological Malignancies in Patients with Abnormal Blood Parameters: A Systematic Review and Meta-Analysis 2025. Clinical Oncology Research and Reports, 05(01), 01-07. https://doi.org/10.31579/2693-4787/050

Vancouver

** MW, Degefa HD, Germame YA, Workineh EG, * BMA, * MBM, et al. Prevalence of Bone Marrow–Confirmed Hematological Malignancies in Patients with Abnormal Blood Parameters: A Systematic Review and Meta-Analysis 2025. Clinical Oncology Research and Reports. 2026;05(01):01-07. doi:10.31579/2693-4787/050

BibTeX
@article{2026,
  author = {**, Misgana Woldemeskel and Degefa, Haile Derese and Germame, Yodit Abera and Workineh, Eyerusalem Getaneh and *, Bereket Muhabaw Agedaw and *, Maria Bilal Mohammed and Wachemo, Leilt Zewdie and Alemu, Yared Getachew and Balcha, Thomas Daba and Gebremeskel, Blen and Habteyesus, Aryamawit Neway and Tesfaye, Dagmawi Workalemahu and Ashenafi, Melak Mekonnen and Chane, Loza Getachew and *, Feven Gidey and Dechassa, Tinsae Tibebu and Tarekegn, Tewodros Kassahun},
  title = {Prevalence of Bone Marrow–Confirmed Hematological Malignancies in Patients with Abnormal Blood Parameters: A Systematic Review and Meta-Analysis 2025},
  journal = {Clinical Oncology Research and Reports},
  year = {2026},
  volume = {05},
  number = {01},
  pages = {01--07},
  doi = {10.31579/2693-4787/050}
}
Kostenlos starten →